Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 8 | 2012 | 390 | 0.640 |
Why?
|
| Cognition | 7 | 2012 | 576 | 0.520 |
Why?
|
| Motor Activity | 3 | 2012 | 356 | 0.440 |
Why?
|
| Osteoarthritis, Knee | 4 | 2014 | 96 | 0.360 |
Why?
|
| Postmenopause | 10 | 2012 | 461 | 0.340 |
Why?
|
| Learning | 1 | 2011 | 88 | 0.330 |
Why?
|
| Tamoxifen | 2 | 2012 | 66 | 0.320 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2009 | 38 | 0.300 |
Why?
|
| Medroxyprogesterone Acetate | 5 | 2010 | 115 | 0.280 |
Why?
|
| Estrogens, Conjugated (USP) | 5 | 2010 | 159 | 0.260 |
Why?
|
| Women's Health | 5 | 2010 | 242 | 0.240 |
Why?
|
| Exercise Therapy | 3 | 2013 | 283 | 0.220 |
Why?
|
| Hot Flashes | 3 | 2014 | 51 | 0.220 |
Why?
|
| Dementia | 4 | 2010 | 252 | 0.220 |
Why?
|
| Breast Neoplasms | 3 | 2012 | 803 | 0.220 |
Why?
|
| Aged | 22 | 2014 | 10998 | 0.210 |
Why?
|
| Neuropsychological Tests | 4 | 2012 | 372 | 0.180 |
Why?
|
| Female | 30 | 2014 | 21490 | 0.170 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2008 | 222 | 0.170 |
Why?
|
| Obesity | 4 | 2013 | 1244 | 0.170 |
Why?
|
| Aging | 5 | 2012 | 1010 | 0.170 |
Why?
|
| Knee Joint | 2 | 2014 | 151 | 0.170 |
Why?
|
| Menopause | 2 | 2014 | 111 | 0.170 |
Why?
|
| Humans | 33 | 2014 | 34474 | 0.160 |
Why?
|
| Weight-Bearing | 3 | 2014 | 47 | 0.150 |
Why?
|
| Middle Aged | 19 | 2014 | 12703 | 0.150 |
Why?
|
| Mental Disorders | 3 | 2010 | 127 | 0.140 |
Why?
|
| Sexual Behavior | 2 | 2008 | 129 | 0.130 |
Why?
|
| Single-Blind Method | 3 | 2013 | 214 | 0.130 |
Why?
|
| Exercise | 2 | 2012 | 700 | 0.120 |
Why?
|
| Aged, 80 and over | 7 | 2012 | 4150 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2014 | 583 | 0.120 |
Why?
|
| Treatment Outcome | 7 | 2014 | 3618 | 0.120 |
Why?
|
| Cohort Studies | 5 | 2011 | 1910 | 0.110 |
Why?
|
| Infant, Premature | 2 | 2007 | 80 | 0.110 |
Why?
|
| Telephone | 2 | 2012 | 67 | 0.110 |
Why?
|
| Abdominal Fat | 1 | 2014 | 52 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2014 | 52 | 0.100 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2005 | 58 | 0.100 |
Why?
|
| Weight Loss | 3 | 2013 | 493 | 0.100 |
Why?
|
| Yoga | 1 | 2014 | 53 | 0.100 |
Why?
|
| Diet, Reducing | 1 | 2013 | 109 | 0.100 |
Why?
|
| Depression | 3 | 2012 | 458 | 0.090 |
Why?
|
| Affect | 1 | 2012 | 72 | 0.090 |
Why?
|
| Overweight | 1 | 2013 | 288 | 0.090 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2008 | 22 | 0.090 |
Why?
|
| Mass Screening | 2 | 2011 | 268 | 0.090 |
Why?
|
| Health Status | 2 | 2004 | 411 | 0.080 |
Why?
|
| Physical Exertion | 1 | 2011 | 15 | 0.080 |
Why?
|
| Remote Consultation | 1 | 2011 | 14 | 0.080 |
Why?
|
| Health Services for the Aged | 1 | 2010 | 27 | 0.080 |
Why?
|
| Mental Health Services | 1 | 2010 | 36 | 0.080 |
Why?
|
| Risk Factors | 5 | 2010 | 4136 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2011 | 169 | 0.080 |
Why?
|
| Home Care Services | 1 | 2010 | 51 | 0.080 |
Why?
|
| Memory Disorders | 1 | 2010 | 58 | 0.080 |
Why?
|
| Life Style | 1 | 2011 | 418 | 0.070 |
Why?
|
| Male | 14 | 2014 | 20697 | 0.070 |
Why?
|
| Hormone Replacement Therapy | 1 | 2009 | 96 | 0.070 |
Why?
|
| Estrogens | 1 | 2010 | 210 | 0.070 |
Why?
|
| Hemostasis | 1 | 2008 | 9 | 0.070 |
Why?
|
| Quality of Life | 4 | 2013 | 1032 | 0.070 |
Why?
|
| Running | 1 | 2008 | 21 | 0.070 |
Why?
|
| Acupuncture Therapy | 1 | 2008 | 20 | 0.070 |
Why?
|
| Knee Injuries | 1 | 2008 | 40 | 0.070 |
Why?
|
| Progesterone | 1 | 2008 | 112 | 0.070 |
Why?
|
| Memory | 1 | 2009 | 216 | 0.070 |
Why?
|
| Severity of Illness Index | 5 | 2014 | 922 | 0.070 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2007 | 12 | 0.060 |
Why?
|
| Child Health Services | 1 | 2007 | 26 | 0.060 |
Why?
|
| Training Support | 1 | 2006 | 7 | 0.060 |
Why?
|
| Continuity of Patient Care | 1 | 2007 | 75 | 0.060 |
Why?
|
| Women's Health Services | 1 | 2006 | 12 | 0.060 |
Why?
|
| Research Support as Topic | 1 | 2006 | 36 | 0.060 |
Why?
|
| Lenses | 1 | 2005 | 1 | 0.060 |
Why?
|
| Night Blindness | 1 | 2005 | 1 | 0.060 |
Why?
|
| Sensory Aids | 1 | 2005 | 1 | 0.060 |
Why?
|
| Retinitis Pigmentosa | 1 | 2005 | 2 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 267 | 0.060 |
Why?
|
| Vision, Low | 1 | 2005 | 4 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2005 | 47 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2012 | 565 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2005 | 88 | 0.060 |
Why?
|
| Inflammation | 2 | 2013 | 557 | 0.060 |
Why?
|
| Faculty, Medical | 1 | 2006 | 81 | 0.060 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2005 | 40 | 0.060 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 112 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2006 | 168 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2007 | 240 | 0.050 |
Why?
|
| Body Mass Index | 3 | 2013 | 953 | 0.050 |
Why?
|
| Insulin | 2 | 2005 | 394 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2011 | 2366 | 0.050 |
Why?
|
| Caloric Restriction | 1 | 2005 | 121 | 0.050 |
Why?
|
| Progesterone Congeners | 1 | 2003 | 22 | 0.050 |
Why?
|
| Hippocampus | 1 | 2005 | 225 | 0.050 |
Why?
|
| Prospective Studies | 4 | 2012 | 2461 | 0.050 |
Why?
|
| Perception | 1 | 2004 | 107 | 0.050 |
Why?
|
| Mothers | 1 | 2004 | 94 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2002 | 3 | 0.050 |
Why?
|
| Phytotherapy | 1 | 2003 | 41 | 0.050 |
Why?
|
| Logistic Models | 3 | 2012 | 808 | 0.050 |
Why?
|
| Soybeans | 1 | 2003 | 42 | 0.050 |
Why?
|
| Vitamin A | 1 | 2002 | 22 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2002 | 28 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2002 | 17 | 0.050 |
Why?
|
| Isoflavones | 1 | 2003 | 104 | 0.050 |
Why?
|
| Intraoperative Care | 1 | 2002 | 54 | 0.050 |
Why?
|
| Cardiotonic Agents | 1 | 2002 | 52 | 0.050 |
Why?
|
| Soybean Proteins | 1 | 2003 | 102 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2003 | 145 | 0.050 |
Why?
|
| Body Weight | 2 | 2014 | 343 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 200 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2002 | 228 | 0.040 |
Why?
|
| Pain Measurement | 2 | 2013 | 385 | 0.040 |
Why?
|
| North Carolina | 3 | 2012 | 1612 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 1209 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2003 | 441 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2014 | 310 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2008 | 803 | 0.040 |
Why?
|
| Time Factors | 3 | 2011 | 2352 | 0.040 |
Why?
|
| Pain | 2 | 2012 | 330 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 819 | 0.040 |
Why?
|
| Double-Blind Method | 3 | 2005 | 597 | 0.040 |
Why?
|
| Adult | 5 | 2012 | 10015 | 0.030 |
Why?
|
| United States | 4 | 2010 | 4267 | 0.030 |
Why?
|
| Linear Models | 2 | 2012 | 464 | 0.030 |
Why?
|
| Mobility Limitation | 2 | 2009 | 222 | 0.030 |
Why?
|
| Child Development | 2 | 2007 | 47 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2008 | 446 | 0.030 |
Why?
|
| Thigh | 1 | 2014 | 43 | 0.030 |
Why?
|
| Patellofemoral Joint | 1 | 2014 | 16 | 0.030 |
Why?
|
| Health Behavior | 2 | 2008 | 246 | 0.030 |
Why?
|
| Research Design | 2 | 2009 | 337 | 0.030 |
Why?
|
| Quadriceps Muscle | 1 | 2014 | 35 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 102 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2014 | 143 | 0.030 |
Why?
|
| Gait | 1 | 2014 | 134 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2009 | 1386 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2014 | 193 | 0.020 |
Why?
|
| Age Factors | 2 | 2008 | 1261 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2007 | 730 | 0.020 |
Why?
|
| Risk | 2 | 2004 | 325 | 0.020 |
Why?
|
| Incidence | 2 | 2008 | 1288 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2013 | 257 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2004 | 508 | 0.020 |
Why?
|
| Psychometrics | 1 | 2012 | 143 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2008 | 1607 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2011 | 74 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2010 | 53 | 0.020 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2010 | 4 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2010 | 34 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2010 | 107 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 306 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 984 | 0.020 |
Why?
|
| Factor VII | 1 | 2008 | 4 | 0.020 |
Why?
|
| Protein C | 1 | 2008 | 3 | 0.020 |
Why?
|
| Placebo Effect | 1 | 2008 | 18 | 0.020 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2008 | 16 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 107 | 0.020 |
Why?
|
| Antigens | 1 | 2008 | 36 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 48 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2011 | 369 | 0.020 |
Why?
|
| Anthropometry | 1 | 2008 | 88 | 0.020 |
Why?
|
| Libido | 1 | 2008 | 5 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2009 | 262 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2009 | 251 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 168 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 627 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 589 | 0.020 |
Why?
|
| Erectile Dysfunction | 1 | 2008 | 71 | 0.020 |
Why?
|
| Infant Care | 1 | 2007 | 3 | 0.020 |
Why?
|
| Comprehensive Health Care | 1 | 2007 | 6 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2007 | 35 | 0.020 |
Why?
|
| Prevalence | 1 | 2010 | 1034 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 560 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2007 | 155 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 934 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2007 | 81 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 612 | 0.020 |
Why?
|
| Financing, Organized | 1 | 2006 | 17 | 0.020 |
Why?
|
| Budgets | 1 | 2006 | 11 | 0.020 |
Why?
|
| Benchmarking | 1 | 2006 | 26 | 0.010 |
Why?
|
| Sex Factors | 1 | 2008 | 707 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2007 | 155 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2007 | 480 | 0.010 |
Why?
|
| Schools, Medical | 1 | 2006 | 46 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 509 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2007 | 214 | 0.010 |
Why?
|
| Eye Protective Devices | 1 | 2005 | 7 | 0.010 |
Why?
|
| Electrochemistry | 1 | 2005 | 17 | 0.010 |
Why?
|
| Locomotion | 1 | 2005 | 37 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2005 | 170 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2006 | 190 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 97 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2005 | 153 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 265 | 0.010 |
Why?
|
| Equipment Design | 1 | 2005 | 192 | 0.010 |
Why?
|
| Maternal Behavior | 1 | 2004 | 4 | 0.010 |
Why?
|
| Mother-Child Relations | 1 | 2004 | 16 | 0.010 |
Why?
|
| Birth Weight | 1 | 2004 | 51 | 0.010 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2004 | 18 | 0.010 |
Why?
|
| Infant | 1 | 2007 | 1122 | 0.010 |
Why?
|
| Gestational Age | 1 | 2004 | 134 | 0.010 |
Why?
|
| Climacteric | 1 | 2003 | 7 | 0.010 |
Why?
|
| Tocopherols | 1 | 2002 | 4 | 0.010 |
Why?
|
| Herpes Zoster | 1 | 2002 | 12 | 0.010 |
Why?
|
| Leukemia | 1 | 2002 | 43 | 0.010 |
Why?
|
| Urinary Incontinence | 1 | 2003 | 68 | 0.010 |
Why?
|
| Lymphoma | 1 | 2002 | 40 | 0.010 |
Why?
|
| Social Support | 1 | 2003 | 195 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2003 | 197 | 0.010 |
Why?
|
| Young Adult | 1 | 2008 | 2825 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2002 | 207 | 0.010 |
Why?
|
| Length of Stay | 1 | 2002 | 335 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 1946 | 0.010 |
Why?
|
| Survival Rate | 1 | 2002 | 925 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2002 | 529 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2002 | 440 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2002 | 849 | 0.010 |
Why?
|
| Animals | 1 | 2005 | 8544 | 0.010 |
Why?
|